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Background
The prognostic significance of the number of tumor-
infiltrating T cells has been demonstrated for many
tumor types. In contrast, the significance of the tumor-
infiltrating T cell clonality, which reflects the preferen-
tial infiltration or expansion of T cell clones in the
tumor microenvironment, has not been clear because of
the technical hurdles required for evaluating each T cell
clone in the tumor. In order to delineate the complexity
of T cell responses and define correlates of a protective
immunity, we applied a recently developed deep T cell
receptor (TCR)-sequencing technology (immunoSEQ) to
paired frozen tumor tissues and peripheral blood mono-
nuclear cells from 99 ovarian cancer patients.
Methods
Rearranged b TCR chain DNA sequences were sequenced
using immunoSEQ technology. Frequency of each T cell
clone was obtained from the copy number of the
sequence. T cell clonality of the specimens was calculated
from entropy of TCR sequences. Spontaneous immune
responses against tumor-associated antigens (NY-ESO-1,
MAGE-A1, MAGE-A3 and p53) were evaluated by mea-
suring serum antibodies by ELISA.
Results
Approximately 3(±3)×106and 4(±2)×106 full-length TCR
beta chain sequences were obtained corresponding to the
detection limit for T cell frequency at 3×10-7and 2×10-7
for tumor and blood samples, respectively. In patients
who had spontaneous antibodies against a panel of
tumor-associated antigens, more clonal T cell infiltration
was associated with longer progression-free survival.
In sharp contrast, clonal infiltration was a worse prognos-
tic factor in patients without detectable humoral immune
responses against surrogate tumor antigens. From
sequence based analyses, we found a set of shared TCR
sequences among patients.
Conclusion
Deep TCR sequencing using immunoSEQ technology is
a powerful tool to characterize tumor-infiltrating T cell
clonality using frozen tumor tissues. Our analyses indi-
cate that evaluation for spontaneous anti-tumor immune
responses is required to correctly understand the prog-
nostic significance of tumor-infiltrating T cells.
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